Inhaled corticosteroids and the hypothalamic–pituitary–adrenal (HPA) axis: do we understand their interaction?
- 31 July 2000
- journal article
- editorial
- Published by Elsevier in Respiratory Medicine
- Vol. 94 (7) , 627-631
- https://doi.org/10.1053/rmed.2000.0791
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Adrenal Effects and Pharmacokinetics of CFC-free Beclomethasone Dipropionate: a 14-Day Dose-Response StudyJournal of Pharmacy and Pharmacology, 1999
- ReplyJournal of Allergy and Clinical Immunology, 1999
- Hypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid TherapyNeuroimmunomodulation, 1998
- Chlorofluorocarbon-free inhalers: are we ready for the change?European Respiratory Journal, 1998
- A low dose ACTH test to assess the function of the hypothalamic–pituitary–adrenal axisClinical Endocrinology, 1996
- Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens.Thorax, 1995
- Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1–24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamicsJournal of Endocrinology, 1993
- Acute adrenal insufficiency associated with high dose inhaled steroids.BMJ, 1992
- The use of low doses of ACTH in the investigation of adrenal function in manJournal of Endocrinology, 1991
- NOCTURNAL ADRENAL SUPPRESSION IN ASTHMATIC CHILDREN TAKING INHALED BECLOMETHASONE DIPROPIONATEThe Lancet, 1986